In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Heart and Stroke - Blog

Read the latest blog on research and content on Heart and Stroke

Welcome to the ESC Council on Stroke Blog.

This blog is your go-to source for the latest insights on the intersection of heart and brain. We feature commentaries on high-impact studies, interviews with leading researchers, clinical case discussions, and coverage of major conferences.

Primarily driven by fellows in training and early-career professionals, the blog fosters a collaborative environment for the next generation of cardiovascular and stroke experts. We aim to engage clinicians, researchers, and trainees, providing valuable content to improve patient care and inspire new research.
If you are interested in contributing, complete this form.

The opinions expressed here are those of the authors and not necessarily those of the ESC.
Contents do not constitute medical advice. 



11/06/2025 - Endovascular treatment of stroke due to medium vessel occlusion does not lead to better outcomes than usual care

Endovascular thrombectomy (EVT) is a well-established and effective treatment for acute ischemic stroke due to large-vessel occlusion, with proven impact on patient mortality and functional outcomes. However, whether this benefit holds true for stroke due to medium-vessel occlusion is unclear

Written by Doctor Alberto Fisce

11/05/2025 - Lights and shadows about the OPTION trial

The OPTION trial is an international prospective study involving 1,600 patients who underwent catheter ablation for atrial fibrillation (AF). Patients were randomised to receive either anticoagulant therapy (OAC) or left atrial appendage closure (LAAC) device.

Written by Doctor Marco Micillo

11/04/2025 - Atrial Fibrillation Burden: New Consensus Definition

An international expert group, led by Prof. Dr. Wolfram Doehner, has proposed a standardized uniform definition of atrial fibrillation burden (AF burden). This recommendation is intended to enhance risk assessment, support therapeutic decision-making, and improve comparability in clinical studies.

Written by Professor Wolfram Doehner

10/03/2025 - Transforming the Management of AF-Related Stroke with Virtual Twins and AI: The TARGET Project

Atrial fibrillation (AF), the most common heart arrhythmia globally, leads to severe complications like AF-related stroke (AFRS), a debilitating condition with high mortality, long hospital stays, and poor recovery outcomes.

Written by Professor Sandra Ortega-Martorell & Doctor Ivan Olier-Caparroso

03/02/2025 - No evidence of stroke risk reduction in patients with atrial cardiopathy undergoing anticoagulation therapy for secondary prevention

Atrial cardiopathy is associated with stroke in the absence of clinically apparent atrial fibrillation. It is unknown whether anticoagulation, which has proven benefit in atrial fibrillation, prevents stroke in patients with atrial cardiopathy and no atrial fibrillation.

Written by Doctor Kevin Serafini

10/01/2025 - Association between exposure to air pollution and increased ischaemic stroke incidence: a retrospective population-based cohort study (EP-PARTICLES study)

Short-term effects of Polish smog, particularly benzo(alpha)pyrene [B(a)P], are unclear. We aimed to examine the association between short-term exposure to air pollution and ischaemic stroke (IS) incidence.

Written by Mr. Michal Swieczkowski

 

Figure Blog November 24.png 28/11/2024 - A new ESC consensus statement on stroke risk management in carotid atherosclerotic disease   

Carotid atherosclerotic disease (CarAD) is a prevalent condition worldwide, especially among the ageing population. It is a significant cause of ischemic strokes and serves as a marker for an increased risk of myocardial infarction and other ischaemic cardiovascular events. With CarAD underlying about 20% of strokes – many of which are disabling or fatal – optimal medical therapy and revascularization are crucial.

 Written by Doctor Marta Mantovani